Humira

$21B or bust! AbbVie ensures its blockbuster US marathon on Humira will run into 2023
Endpoints
Thu, 04/5/18 - 09:28 am
AbbVie
Humira
biosimilars
Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica
Fierce Pharma
Sun, 03/25/18 - 11:18 am
Pfizer
Ibrance
television ads
Humira
AbbVie
DTC advertising
Lyrica
5 Must-See Quotes From AbbVie's Management
Yahoo/Motley Fool
Fri, 03/16/18 - 09:27 am
AbbVie
Humira
hepatitis C
Mavyret
Viekira
M&A
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
Wed, 03/14/18 - 09:38 pm
AbbVie
Roche
Humira
Rituxan
Herceptin
Avastin
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Novartis
Humira
biosimilars
AbbVie
Sandoz
Here's How AbbVie Inc. Crushed It in 2017
Yahoo/Motley Fool
Tue, 12/26/17 - 09:48 am
AbbVie
biosimilars
Humira
Imbruvica
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie
7 Things AbbVie's Top Executives Just Said That You'll Want to Know
Motley Fool
Fri, 11/10/17 - 10:19 am
AbbVie
Humira
Imbruvica
Venclexta
Amazon
tax reform
Could pain data give Lilly's baricitinib back its edge?
BioPharma Dive
Tue, 11/7/17 - 09:48 am
Eli Lilly
baricitinib
Humira
AbbVie
rheumatoid arthritis
Humira back on top of TV spending list for October, ahead of Lyrica and Victoza
Fierce Pharma
Mon, 11/6/17 - 10:12 am
Humira
Lyrica
Victoza
AbbVie
Pfizer
Novo Nordisk
television ads
DTC ads
AbbVie Overpromises on Humira
Bloomberg
Sat, 11/4/17 - 08:47 am
AbbVie
Humira
There's a Lot to Like in AbbVie's Q3 Update
Motley Fool
Fri, 10/27/17 - 02:44 pm
AbbVie
earnings
Humira
Imbruvica
Mavyret
AbbVie says Humira sales will balloon to $21 bln in 2020, shares rise
Yahoo/Reuters
Fri, 10/27/17 - 11:05 am
AbbVie
Humira
earnings
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
AbbVie
psoriasis
risankizumab
Humira
Stelara
clinical trials
Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September
Fierce Pharma
Mon, 10/9/17 - 11:24 am
Pfizer
Lyrica
AbbVie
Humira
drug ads
television ads
3 Big Pharma Stocks Set to Succeed
Motley Fool
Thu, 10/5/17 - 09:36 am
AbbVie
Humira
patents
Allergan
Botox
Celgene
Revlimid
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
RAPS.org
Mon, 10/2/17 - 11:18 am
AbbVie
Amgen
Humira
biosimilars
Medicare
Medicaid
CMS
How Good Is AbbVie's Humira Deal With Amgen?
Motley Fool
Fri, 09/29/17 - 10:06 am
AbbVie
Amgen
Humira
biosimilars
Amjevita

Pages